Search Results For :: patient engagement

• World Mobile Applications Market - Advanced Technologies, Global Forecast (2010 - 2015)

  The success of Apple’s App Store has not only established the salability of mobile applications, but has also shown that the best of these offer the potential to generate enormous revenues. Several telecom giants have thus begun providing a dedicated application stores to their users, so much so that more than 3 million unique applications are currently on air for communications, games, multimedia, productivity, travel, and utility purposes.

  • Published: August 2010
  • Price: $ 4950
  • TOC Available:

• Obama’s Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets – (Pharmaceuticals, Medical devices and Health insurance)

  The US healthcare system ranks 37 among health care systems of about 200 worldwide countries ranked by World Health Organization. US health care system is considered as one of the most expensive healthcare system in the world, spending about 16% of its GDP on healthcare. However the rising healthcare costs and increasing health premiums rates along with high number of uninsured people (about 47 million i.e. 16% of the total population) are among the significant factors contributing to the need of health reform in the US. Health reform in the US is looked upon as an initiative towards provision of qualitative and affordable health coverage for all Americans, decrease in rising burden of healthcare costs and improvement in quality & efficiency of health care. Obama has signed health reform in to law, recently in March 2010, to improve the inefficiencies of the existing health care structure. The health reform bill outlays several provisions such as universal health coverage, cost containment, increase in insurance market competition, excise tax on medical device manufacturers and lower drug costs for Medicaid and Medicare are few to mention. Thus the provisions in the health reform directly and indirectly impact the US healthcare/pharmaceutical industry and its stakeholders.

  • Published: August 2010
  • Price: $ 4950
  • TOC Available:

• Healthcare Mobility Solutions Market by Products & Services (Mobile Devices, Mobile Apps, Enterprise Platforms), Application (Patient Care, Operations, Workforce Management), End User (Payers, Providers, Patients) - Global Forecast to 2020

  The global healthcare mobility solutions market is segmented on the basis of products and services, applications, and end users. Based on products and services, the market is segmented into mobile devices, mobile applications, and enterprise platforms. The mobile devices market covers mobile computers, RFID scanners, barcode scanners, and others. On the basis of applications, the market is classified into patient care management, operations management, and workforce management. By end users, the market is divided into payers, providers, and patients. The global healthcare mobility solutions market is expected to reach $84,817.9 Million by 2020 from $24,335.3 Million in 2015, at a CAGR of about 28.4% from 2015 to 2020.

  • Published: May 2015
  • Price: $ 4950
  • TOC Available:

• Guidewires Market by Material (Nitinol, Stainless Steel, Hybrid), Product (Surgical, Diagnostic (Hydrophilic, Hydrophobic)), Application (Cardiology, Vascular, Neurology, GIT, ENT, Urology, Oncology), End User (Hospital, ASCs) - Global Forecast to 2022

  The global guidewires market is projected to reach USD 764.0 Million by 2022 from USD 605.2 Million in 2017, at a CAGR of 4.8%. The growth witnessed by guidewires is mainly driven by the growing target patient population, continuous product launches by major manufacturers, increasing availability of medical reimbursements for guidewires across developed countries, and rising adoption of minimally invasive surgical procedures across major countries. Major players operating in the market include Boston Scientific (US), Abbott (US), Medtronic (Ireland), Terumo (Japan), and Cook Group (US). Other prominent players present in this market include Cardinal Health (US), Olympus (Japan), Johnson & Johnson (US), B. Braun (Germany), C.R. Bard (US), Teleflex (US), and Angiodynamics (US).

  • Published: February 2018
  • Price: $ 4950
  • TOC Available:

• Elastomeric Infusion Pumps Market by Type (Continuous Rate and Variable Rate), Application (Chemotherapy, Pain Management, Antibiotics), End-use Industry (Hospitals, Ambulatory Surgical Centers, Home-care Settings), and Region - Global Forecast to 2030

  The global elastomeric infusion pumps market, valued at US$1.09 billion in 2024, stood at US$1.15 billion in 2025 and is projected to advance at a resilient CAGR of 5.3% from 2025 to 2030, culminating in a forecasted valuation of US$1.49 billion by the end of the period. The growing prevalence of chronic illness, aging population, and rising surgical procedures drive the need for reliable, patient-friendly drug delivery systems.

  • Published: November 2025
  • Price: $ 4950
  • TOC Available:

• eHealth Market by Solutions (EMR, PACS & VNA, RIS, LIS, CVIS, Telehealth, eRx, HIE, Patient Portal, Medical Apps), Services (Remote Patient Monitoring, Diagnostic Services), End User & Region - Global Forecast to 2025

  The global eHealth market growth is primed to transition from $69.5 billion in 2020 to $193.8 billion by 2025, showcasing a strong CAGR of 22.8%. Key drivers include the shift towards patient-centric care, increased digitization, regulatory compliance requirements, and cost reduction in healthcare services.

  • Published: January 2021
  • Price: $ 4950
  • TOC Available:

• Nutraceuticals & Dietary Supplements Industry Outlook (2024-2025) – Personalized Nutrition, Sustainability, and Technological Advancements Shaping the Future of Wellness

  The nutraceuticals & dietary supplements industry is undergoing transformative shifts driven by sustainability, technology, and innovation. These changes focus on improving product efficacy, personalization, and consumer engagement, signaling a move toward more sustainable and technologically advanced solutions.

  • Published: December 2024
  • Price: $ 4950
  • TOC Available:

• North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017

  The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.

  • Published: April 2013
  • Price: $ 4950
  • TOC Available:

• Bio-Implants Market - by Type (Cardiovascular, Spine, Orthopedics, Trauma, Dental), by ROA (Surgical/Injectable), by Origin (Allo/Auto/Xenograft, Synthetic) & Materials (Ceramics, Biomaterial, Alloys, Polymers) - Global Trends &, Forecasts till 2017

  Bio-implants can be defined as prostheses used to regularize physiological functions. They are made up of biosynthetic materials like collagen, and tissue-engineered products like artificial skin or tissues. Most bioengineered products like cardiac pacemakers and orthopedic artificial implants are also covered under bio-implants, since they are implanted entirely in the patient’s body.

  • Published: September 2012
  • Price: $ 4950
  • TOC Available:

• Optical Imaging Market by Product (Cameras, Lenses), Technique (OCT, HIS, NIR, PAT), Therapeutic Area (Ophthalmology, Dermatology, Oncology), Application (Pathological, Intraoperative), End User (Hospital, Research Labs) & Region - Global Forecast to 2027

  The global optical Imaging market growth is primed to transition from USD 1.5 billion in 2022 to USD 2.9 billion by 2027, showcasing a strong CAGR of 13.5%. Precise differentiation between soft tissues and affected tissues, reduced patient exposure to eradicating radiations, increased prevalence of age related macular degeneration, increased GDP expenditure on healthcare among rapidly growing economies, increased need and adoption of non invasive tools for rapid scanning and identification of disorders coupled with increasing research to adopt these tools in the field of dentistry, gastroenterology, and gynecology are factors influencing the market growth and adoption of optical imaging systems.

  • Published: February 2023
  • Price: $ 4950
  • TOC Available:

• FIRST
• PREVIOUS

Records 51 to 60 of 60